TNYA
Tenaya Therapeutics, Inc. · Healthcare · Market cap $152.3M
Insiders sold $20K net in the last 90 days ·2 sellers, 0 buyers· latest Form 4 filed Aug 18, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$6.0M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 12, 2026
Ali Faraz
Tenaya Therapeutics, Inc. (TNYA) has 19 SEC Form 4 filings (40 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 12, 2026.
Inside the rolling window, 4 insiders at Tenaya Therapeutics, Inc. reported no open-market purchases and 17 open-market sales totaling $6.0M. The most active filer is 10% Owner COLUMN GROUP III GP, LP with 6 filings. The most recent open-market filing is a sale of 22,232 shares by Chief Executive Officer Ali Faraz, dated Aug 17, 2026, worth $16K.
- Industry:Biotechnology
- CEO:Faraz Ali
- Employees:70
- HQ:South San Francisco, CA, US
- IPO:2021-07-30
| Source | |||||||
|---|---|---|---|---|---|---|---|
Ali FarazFirst in 3 months | Chief Executive Officer | Sale | 22,232 | $16K | Aug 18 | -2.8% | SEC ↗ |
Tingley WhittemoreFirst in 3 months | Chief Medical Officer | Sale | 5,787 | $4K | Aug 18 | -2.8% | SEC ↗ |
Higa TomohiroFirst in 3 months | SVP, Finance | Sale | 1,485 | $1K | May 19 | -13.8% | SEC ↗ |
Ali FarazFirst in 3 months | Chief Executive Officer | Sale | 3,390 | $3K | May 19 | -13.8% | SEC ↗ |
Tingley WhittemoreFirst in 3 months | Chief Medical Officer | Sale | 3,121 | $2K | May 19 | — | SEC ↗ |
| 10% Owner | Sale | 658,440 | $405K | Feb 26 | — | SEC ↗ | |
| 10% Owner | Sale | 3,511,826 | $2.0M | Feb 26 | — | SEC ↗ | |
| 10% Owner | Sale | 523,734 | $322K | Feb 24 | — | SEC ↗ | |
| 10% Owner | Sale | 306,000 | $183K | Feb 24 | — | SEC ↗ | |
Higa TomohiroFirst in 3 months | SVP, Finance | Sale | 3,469 | $2K | Feb 17 | — | SEC ↗ |
Tingley WhittemoreFirst in 3 months | Chief Medical Officer | Sale | 3,518 | $2K | Feb 17 | — | SEC ↗ |
Ali FarazFirst in 3 months | Chief Executive Officer | Sale | 14,862 | $10K | Feb 17 | — | SEC ↗ |
| 10% Owner | Sale | 343,717 | $281K | Feb 12 | — | SEC ↗ | |
| 10% Owner | Sale | 4,056,573 | $2.8M | Feb 12 | — | SEC ↗ | |
Tingley WhittemoreFirst filing | Chief Medical Officer | Sale | 2,877 | $4K | Nov 17 | — | SEC ↗ |
Higa TomohiroFirst filing | SVP, Finance | Sale | 1,367 | $2K | Nov 17 | — | SEC ↗ |
Ali FarazFirst filing | Chief Executive Officer | Sale | 3,126 | $4K | Nov 17 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does TNYA have?
Tenaya Therapeutics, Inc. (TNYA) has 19 SEC Form 4 filings (40 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 12, 2026.
When was the most recent SEC Form 4 filing for TNYA?
The most recent Form 4 filing for TNYA on Tracefour is dated Sep 12, 2026.
Who is the most active insider at TNYA?
The most active SEC Form 4 filer at TNYA in the rolling window is 10% Owner COLUMN GROUP III GP, LP, with 6 filings.
What is the net insider flow at TNYA over the last 6 months?
Over the trailing 180 days, insiders at TNYA have net sold $26K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TNYA in the current window?
Inside the rolling window, insiders at TNYA bought $0 and sold $6.0M based on SEC Form 4 filings.
Can I get alerts for TNYA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Tenaya Therapeutics, Inc. (TNYA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Tenaya Therapeutics, Inc. is in the Healthcare sector.